These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 16788959)
1. Sonographic appearance of the uterine cavity following administration of mifepristone and misoprostol for termination of pregnancy. Markovitch O; Tepper R; Klein Z; Fishman A; Aviram R J Clin Ultrasound; 2006; 34(6):278-82. PubMed ID: 16788959 [TBL] [Abstract][Full Text] [Related]
2. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. Guest J; Chien PF; Thomson MA; Kosseim ML BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893 [TBL] [Abstract][Full Text] [Related]
3. Early versus late misoprostol administration after mifepristone for medical abortion. Tendler R; Bornstein J; Kais M; Masri I; Odeh M Arch Gynecol Obstet; 2015 Nov; 292(5):1051-4. PubMed ID: 25911546 [TBL] [Abstract][Full Text] [Related]
4. Use of mifepristone and sublingual misoprostol for early medical abortion. Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490 [TBL] [Abstract][Full Text] [Related]
5. Mifepristone and misoprostol for early abortion when no gestational sac is present. Schaff EA; Fielding SL; Eisinger S; Stadalius L Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464 [TBL] [Abstract][Full Text] [Related]
6. Medical abortion outcomes after a second dose of misoprostol for persistent gestational sac. Reeves MF; Kudva A; Creinin MD Contraception; 2008 Oct; 78(4):332-5. PubMed ID: 18847584 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion. Dahiya K; Mann S; Nanda S Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288 [TBL] [Abstract][Full Text] [Related]
8. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. Jain JK; Meckstroth KR; Mishell DR Am J Obstet Gynecol; 1999 Dec; 181(6):1386-91. PubMed ID: 10601917 [TBL] [Abstract][Full Text] [Related]
9. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol. Ashok PW; Flett GM; Templeton A Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062 [TBL] [Abstract][Full Text] [Related]
10. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion. Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. Murthy AS; Creinin MD; Harwood B; Schreiber C Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632 [TBL] [Abstract][Full Text] [Related]
12. Simplified medical abortion screening: a demonstration project. Raymond EG; Tan YL; Comendant R; Sagaidac I; Hodorogea S; Grant M; Sanhueza P; Van Pratt E; Gillespie G; Boraas C; Weaver MA; Platais I; Bousieguez M; Winikoff B Contraception; 2018 Apr; 97(4):292-296. PubMed ID: 29170088 [TBL] [Abstract][Full Text] [Related]
13. Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial). van den Berg J; Hamel CC; Snijders MP; Coppus SF; Vandenbussche FP BMC Pregnancy Childbirth; 2019 Nov; 19(1):443. PubMed ID: 31775677 [TBL] [Abstract][Full Text] [Related]
14. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss. Schreiber CA; Creinin MD; Atrio J; Sonalkar S; Ratcliffe SJ; Barnhart KT N Engl J Med; 2018 Jun; 378(23):2161-2170. PubMed ID: 29874535 [TBL] [Abstract][Full Text] [Related]
15. Concurrent use of mifepristone and misoprostol for early medical abortion. Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656 [TBL] [Abstract][Full Text] [Related]
17. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Rossi B; Creinin MD; Meyn LA Contraception; 2004 Oct; 70(4):313-7. PubMed ID: 15451336 [TBL] [Abstract][Full Text] [Related]
18. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan. Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of early medical abortion using low-dose mifepristone and buccal misoprostol in women with no defined intrauterine gestational sac. Goldstone P; Michelson J; Williamson E Contraception; 2013 Jun; 87(6):855-8. PubMed ID: 23158804 [TBL] [Abstract][Full Text] [Related]
20. Comparison of mifepristone combination with misoprostol and misoprostol alone in the management of intrauterine death: condensation - misoprostol and mifepristone combination is more effective than misoprostol alone in the management of intrauterine death. Sharma D; Singhal SR; Poonam ; Paul A; Kunika Taiwan J Obstet Gynecol; 2011 Sep; 50(3):322-5. PubMed ID: 22030047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]